Status:
COMPLETED
Consequence of Lifetime Isolated Growth Hormone Deficiency
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsors:
Genentech, Inc.
Conditions:
Growth Hormone Deficiency
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Growth hormone (GH) deficiency (GHD) in adulthood has been associated with changes in body composition (e.g. increased abdominal obesity, and reduced muscle mass), in organ functions (e.g. reduced car...
Detailed Description
SPECIFIC AIM 1: To study anthropometric parameters, cardiovascular and metabolic status and cardiovascular risk profile, including inflammatory markers of cardiovascular relevance, muscle strength, bo...
Eligibility Criteria
Inclusion
- Lifetime isolated and untreated growth hormone deficiency
Exclusion
- Age below 18 years, pregnancy, diabetes
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00149708
Start Date
September 1 2005
End Date
December 1 2009
Last Update
June 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal University of Sergipe
Aracaju, Sergipe, Brazil, 49060